600064 南京高科
2026/03 - 三个月
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入606,798-42.81%3,418,2171,980,2574,733,0384,490,061
减:营业总成本607,373-39.15%3,267,3921,982,3134,564,9614,095,956
    其中:营业成本477,976-43.04%2,626,1001,543,1954,143,8663,649,047
               财务费用47,6963.67%192,943209,022220,384177,024
               资产减值损失----(639,051)(773,775)(608,242)(2,743)
公允价值变动收益(109,000)227.44%(211,047)24,779(140,770)(242,623)
投资收益718,2025.32%1,998,8972,293,6151,964,6752,405,334
    其中:对联营企业和合营企业的投资收益705,8354.95%1,901,8762,129,4471,829,7262,096,334
营业利润624,095-11.20%1,242,2171,504,9841,367,5402,650,414
利润总额624,042-11.44%1,708,4141,507,9231,369,9622,651,635
减:所得税费用(17,085)-455.68%(19,369)(133,472)(112,586)171,739
净利润641,128-8.39%1,727,7831,641,3951,482,5492,479,895
减:非控股权益14,16083.37%(102,442)(83,835)(77,597)77,522
股东净利润626,968-9.42%1,830,2261,725,2301,560,1462,402,374

市场价值指针
每股收益 (元) *0.362-9.50%1.0580.9970.9021.388
每股派息 (元) *----0.3200.3000.2800.420
每股净资产 (元) *11.4112.38%11.03810.86910.1369.572
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容